Takeda Pharmaceutical

(NYSE) TAK

Current Price$16.15

Market Cap$51.03B

Since IPO (2010)-4%

5 Year+15%

1 Year+13%

1 Month-1%

Takeda Pharmaceutical Financials at a Glance

Market Cap

$51.03B

Revenue (TTM)

¥4.55T

Net Income (TTM)

¥193.19B

EPS (TTM)

$0.41

P/E Ratio

39.14

Dividend

$0.32

Beta (Volatility)

0.33 (Low)

Dividend

$0.32

Beta (Volatility)

0.33 (Low)

Price

$16.15

Volume

3,183,845

Open

$16.10

Price

$16.15

Volume

3,183,845

Open

$16.10

Previous Close

$16.15

Daily Range

$16.04 - $16.27

52-Week Range

$12.99 - $18.90

Dividend

$0.32

Beta (Volatility)

0.33 (Low)

Price

$16.15

Volume

3,183,845

Open

$16.10

Previous Close

$16.15

Daily Range

$16.04 - $16.27

52-Week Range

$12.99 - $18.90

TAK News

drug development pharmaceutical pharma research researchers doctors

2 Beaten-Down Dividend Stocks That Haven't Been This Cheap In More Than a Decade

David Jagielski, CPANov 16, 2022

3 High-Yielding Dividend Stocks Near Their 52-Week Lows

David Jagielski, CPAOct 19, 2022

Got $5,000? These 2 Dividend Stocks Haven't Been This Cheap in Years

David Jagielski, CPASep 14, 2022

Want Loads of Passive Income? Avoid These 3 (Very) Tempting Mistakes

Alex CarchidiJun 11, 2022

Page 1

TAK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Takeda Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

47,455

CEO

Christophe Weber, PhD

Website

www.takeda.com

Headquarters

Tokyo, 103-8668, JP

TAK Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

11%

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

2.55%

Dividend Yield

1.99%

Payout Ratio

1.63%

Stock Overview

Market Cap

$51.03B

Shares Outstanding

3.16B

Volume

3.18M

Avg. Volume

2.99M

Financials (TTM)

Gross Profit

¥2.44T

Operating Income

¥573.04B

EBITDA

¥1.34T

Operating Cash Flow

¥995.32B

Capital Expenditure

-¥186.62B

Free Cash Flow

¥808.70B

Cash & ST Invst.

¥597.63B

Total Debt

¥4.90T

Takeda Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

¥1.11T

+5.8%

Gross Profit

¥543.81B

-19.0%

Gross Margin

48.79%

N/A

Market Cap

$51.03B

N/A

Market Cap/Employee

$1.04M

N/A

Employees

49,281

N/A

Net Income

-¥24.77B

+76.0%

EBITDA

¥214.42B

+18.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

-¥4.31T

-4.8%

Accounts Receivable

¥880.15B

+21.4%

Inventory

¥1.40T

+15.2%

Long Term Debt

¥4.39T

+10.6%

Short Term Debt

¥514.38B

-6.3%

Return on Assets

1.24%

N/A

Return on Invested Capital

3.65%

N/A

Free Cash Flow

-¥26.01B

-115.0%

Operating Cash Flow

¥19.66B

-91.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EWEdwards Lifesciences Corporation

EWEdwards Lifesciences Corporation$86.51-1.18%

BDXBecton, Dickinson and Company

BDXBecton, Dickinson and Company$147.24-0.35%

CAHCardinal Health, Inc.

CAHCardinal Health, Inc.$199.84-0.26%

HLNHaleon plc

HLNHaleon plc$9.32+0.87%

AAgilent Technologies, Inc.

AAgilent Technologies, Inc.$115.83+0.65%

ALCAlcon Inc.

ALCAlcon Inc.$66.35-1.99%

RMDResMed Inc.

RMDResMed Inc.$206.10-0.90%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ASTCAstrotech

ASTCAstrotech$13.81+4.59%

NOKNokia

NOKNokia$15.68-0.05%

INTCIntel

INTCIntel$121.77-0.01%

NIONio

NIONio$5.75+0.09%

FFord Motor Company

FFord Motor Company$15.88+0.04%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.92+0.01%

IRENIren

IRENIren$67.84+0.13%

Questions About TAK

What is the current price of Takeda Pharmaceutical?

Takeda Pharmaceutical is trading at $16.15 per share.

What is the 52-week range for Takeda Pharmaceutical?

Over the past 52 weeks, Takeda Pharmaceutical has traded between $12.99 and $18.90.

How much debt does Takeda Pharmaceutical have?

As of the most recent reporting period, Takeda Pharmaceutical reported total debt of ¥30.69B.

How much cash does Takeda Pharmaceutical have on hand?

Takeda Pharmaceutical reported ¥3.74B in cash and cash equivalents in its most recent financial results.

What is Takeda Pharmaceutical’s dividend yield?

Takeda Pharmaceutical currently has a dividend yield of 1.99%.

Takeda Pharmaceutical

Takeda Pharmaceutical Financials at a Glance

TAK News

Pharmaceutical tariffs: Which countries does the U.S. import the most from?

One Ultra-Cheap High-Yield Dividend Stock to Buy

Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris

2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now

2 Beaten-Down Dividend Stocks That Haven't Been This Cheap In More Than a Decade

3 High-Yielding Dividend Stocks Near Their 52-Week Lows

Got $5,000? These 2 Dividend Stocks Haven't Been This Cheap in Years

Want Loads of Passive Income? Avoid These 3 (Very) Tempting Mistakes

TAK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Takeda Pharmaceutical

TAK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Takeda Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TAK

What is the current price of Takeda Pharmaceutical?

What is the 52-week range for Takeda Pharmaceutical?

How much debt does Takeda Pharmaceutical have?

How much cash does Takeda Pharmaceutical have on hand?

What is Takeda Pharmaceutical’s dividend yield?

Premium Investing Services